TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CAPR

Capricor Therapeutics Inc

Healthcare · Biotechnology

9.10$ -3.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Capricor Therapeutics Inc (CAPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 356 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAPR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
14 16 19 16 9.2 11 35 41 50 59 170 356
12 14 18 16 8.5 11 34 36 43 51 163 323
8.0 14 16 6.1 4.3 3.9 33 35 9.6 15 11 288
8.0 14 16 14 7.3 9.9 33 35 41 39 152 318
0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.4 0.5 10 10 0.1
3.0 0.0 1.3 -0.8 0.3 -0.7 -0.1 0.0 0.0 0.0
0.2 0.3 0.4 0.4 0.6 0.4 0.9 4.6 4.6
0.0 0.0 0.0 0.0 -50 -6.5 -2.2
1.7 1.7 0.1 0.1 0.2 0.0 2.2
20 17 23 5.0 4.6 4.3 6.4 10.0 38 36 25 50
6.3 6.5 4.9 1.7 1.3 0.9 3.0 4.1 24 31 21 36
9.2 0.9 14 0.2 0.4 0.7 0.7 0.8 3.6
1.7 2.5 3.0 1.7 1.3 0.9 2.7 3.7 4.8 6.2 3.3 1.7
9.2 9.2 17 3.4 3.4 3.4 0.1 3.4 3.4
-6.2 -1.0 -4.0 11 4.6 6.8 28 31 12 23 145 306
-22 -35 -54 -52 -67 -74 -88 -108 -137 -159 -200 -305
1.2 1.6 1.9 2.7 2.9 3.7 16 23 25 27 35 46

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?